AssetMark Inc Portfolio holdings
AssetMark runs an investment platform that financial advisors use to build portfolios for their clients and to handle the technology behind them. Financial advisor Ron Cordes and his partners started it in 1996 to solve a problem in their own practice, which was fitting investment strategies into a fee-based, fiduciary business. Cordes and his partners sold the company to Genworth Financial in 2006, and it operated under Genworth names until it took the AssetMark name in 2013. Advisors can place clients in model portfolios of mutual funds and ETFs, and AssetMark also runs its own mutual funds, the GuideMark and GuidePath families. Private equity firm GTCR owns AssetMark through a holding company, after earlier owners that included Aquiline Capital Partners and Genstar Capital.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares Ultra S&P500
SSO
|
+$361M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$279M |
| 3 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$226M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$132M |
| 5 |
Edison International
EIX
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$428M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$207M |
| 3 |
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
|
+$119M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$117M |
| 5 |
AT&T
T
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 64.1% |
| 2 | Technology | 12.54% |
| 3 | Financials | 4.9% |
| 4 | Communication Services | 4.81% |
| 5 | Healthcare | 3.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Celldex Therapeutics
CLDX
$2.35B
| $681 | ﹤0.01% |
21
| – | – |
2026 Q1
2 quarters
|
|
3327
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$44.8M
| $678 | ﹤0.01% |
62
+59
| +1,967% | +$716 |
2025 Q4
3 quarters
|
|
3328
W&T Offshore
WTI
$497M
| $678 | ﹤0.01% |
+190
| New | +$693 |
2026 Q3
0 quarters
|
|
3329
Banco Macro
BMA
$3.83B
| $669 | ﹤0.01% |
10
-1
| -9% | -$83 |
2025 Q4
3 quarters
|
|
3330
Blue Bird Corp
BLBD
$1.97B
| $666 | ﹤0.01% |
12
+10
| +500% | +$675 |
2025 Q2
5 quarters
|
|
3331
Dorian LPG
LPG
$2.11B
| $661 | ﹤0.01% |
12
+7
| +140% | +$336 |
2025 Q4
3 quarters
|
|
3332
VSE Corp
VSEC
$4.57B
| $659 | ﹤0.01% |
+4
| New | +$821 |
2026 Q3
0 quarters
|
|
3333
Nomura Focused Large Growth ETF
LRGG
$296M
| $658 | ﹤0.01% |
22
| – | – |
2025 Q3
4 quarters
|
|
3334
WeRide Inc
WRD
$1.45B
| $658 | ﹤0.01% |
124
-98
| -44% | -$571 |
2025 Q4
3 quarters
|
|
3335
CleanSpark
CLSK
$1.75B
| $657 | ﹤0.01% |
51
+7
| +16% | +$92 |
2025 Q4
3 quarters
|
|
3336
USA Compression Partners
USAC
$3.54B
| $647 | ﹤0.01% |
26
| – | – |
2025 Q4
3 quarters
|
|
3337
CTS Corp
CTS
$1.79B
| $646 | ﹤0.01% |
+11
| New | +$660 |
2026 Q3
0 quarters
|
|
3338
Varex Imaging
VREX
$786M
| $646 | ﹤0.01% |
35
| – | – |
2026 Q1
2 quarters
|
|
|
INDV
3339
DELISTED
Indivior Pharmaceuticals
INDV
| $645 | ﹤0.01% |
+18
| New | +$680 |
2026 Q3
0 quarters
|
|
3340
Beacon Financial Corp
BBT
$2.59B
| $644 | ﹤0.01% |
+23
| New | +$706 |
2026 Q3
0 quarters
|
|
3341
Bankunited
BKU
$3.08B
| $633 | ﹤0.01% |
15
-20
| -57% | -$927 |
2015 Q4
43 quarters
|
|
3342
Hawkins
HWKN
$3.24B
| $630 | ﹤0.01% |
5
+4
| +400% | +$519 |
2025 Q2
5 quarters
|
|
3343
MarineMax
HZO
$1.16B
| $628 | ﹤0.01% |
+12
| New | +$539 |
2026 Q3
0 quarters
|
|
3344
Douglas Dynamics
PLOW
$846M
| $628 | ﹤0.01% |
16
| – | – |
2026 Q2
1 quarter
|
|
3345
First Trust Natural Gas ETF
FCG
$635M
| $627 | ﹤0.01% |
22
+19
| +633% | +$560 |
2025 Q2
5 quarters
|
|
3346
The Bancorp
TBBK
$1.93B
| $626 | ﹤0.01% |
13
-14
| -52% | -$882 |
2025 Q4
3 quarters
|
|
3347
West Fraser Timber
WFG
$5.16B
| $624 | ﹤0.01% |
9
| – | – |
2021 Q2
21 quarters
|
|
3348
Core Scientific
CORZ
$4.1B
| $623 | ﹤0.01% |
39
| – | – |
2025 Q2
5 quarters
|
|
3349
indie Semiconductor
INDI
$369M
| $623 | ﹤0.01% |
213
| – | – |
2025 Q3
4 quarters
|
|
3350
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$107M
| $621 | ﹤0.01% |
+12
| New | +$641 |
2026 Q3
0 quarters
|
|
Similar funds
AssetMark Inc's Q3 2026 Portfolio in Review
As of Q3 2026, AssetMark Inc held 3,948 positions worth $59.5B, up 2.2% from $58.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
AssetMark Inc's Q3 2026 filing shows 390 new, 1,759 increased, 1,017 reduced and 175 closed positions. Its largest new stake was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M. The largest sale was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $428M.
By sector, the portfolio is most concentrated in Miscellaneous at 64% of assets, down from 65% a quarter earlier, followed by Technology and Financials.
- AssetMark Inc's largest Q3 2026 buy was Invesco S&P 500 QVM Multi-factor ETF: 2,240,350 shares worth $101M.
- AssetMark Inc added most to ProShares Ultra S&P500 in Q3 2026, an estimated $361M increase.
- AssetMark Inc's biggest Q3 2026 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $428M.
- AssetMark Inc fully exited Taylor Morrison in Q3 2026, selling an estimated $11.9M.
- AssetMark Inc's ten largest holdings make up 29% of its $59.5B portfolio in Q3 2026.
- AssetMark Inc opened 390 new positions and closed 175 in Q3 2026.
- AssetMark Inc's portfolio value rose 2.2% quarter-over-quarter to $59.5B.
Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.